iX Biopharma Ltd. | Cash Flow
Fiscal year is July-June. All values SGD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
5,082.80
10,561.00
7,703.00
7,390.00
15,094.00
Depreciation, Depletion & Amortization
1,062.50
892.00
932.00
1,281.00
1,407.00
Other Funds
2,112.60
2,797.00
2,514.00
1,429.00
1,914.00
Funds from Operations
1,907.70
6,872.00
9,285.00
4,680.00
11,773.00
Changes in Working Capital
373.00
399.00
127.00
280.00
3,144.00
Net Operating Cash Flow
1,534.60
6,473.00
9,158.00
4,400.00
8,629.00
Capital Expenditures
213.00
407.00
1,161.00
1,119.00
1,186.00
Sale of Fixed Assets & Businesses
1,191.30
-
-
-
-
Net Investing Cash Flow
227.10
1,010.00
2,665.00
1,119.00
1,186.00
Issuance/Reduction of Debt, Net
1,203.70
964.00
533.00
266.00
-
Net Financing Cash Flow
9,247.90
4,663.00
34,913.00
4,829.00
19.00
Net Change in Cash
8,025.90
3,192.00
22,436.00
239.00
10,022.00
Free Cash Flow
1,747.60
6,738.00
10,277.00
5,382.00
9,747.00
Net Assets from Acquisitions
-
-
738.00
-
-
Other Sources
-
129.00
-
-
-
Change in Capital Stock
10,451.50
5,627.00
34,380.00
4,563.00
-
Exchange Rate Effect
85.60
372.00
654.00
451.00
226.00
Other Uses
751.20
732.00
766.00
-
-
About iX Biopharma
View Profile
